152
Participants
Start Date
November 30, 2016
Primary Completion Date
November 30, 2018
Study Completion Date
December 31, 2018
VLY-686 (Tradipitant)
oral capsule
Placebo
placebo oral
Vanda Investigational Site, New York
Vanda Investigational Site, Great Neck
Vanda Investigational Site, Philadelphia
Vanda Investigational Site, Chevy Chase
Vanda Investigational Site, Norfolk
Vanda Investigational Site, Raleigh
Vanda Investigational Site, Salisbury
Vanda Investigational Site, Athens
Vanda Investigational Site, Jacksonville
Vanda Investigational Site, Miami
Vanda Investigational Site, Largo
Vanda Investigational Site, Huntsville
Vanda Investigational Site, Dothan
Vanda Investigational Site, Nashville
Vanda Investigational Site, Chattanooga
Vanda Investigational Site, Jackson
Vanda Investigational Site, Pascagoula
Vanda Investigational Site, Louisville
Vanda Investigational Site, Mentor
Vanda Investigational Site, Huber Heights
Vanda Investigational Site, Indianapolis
Vanda Investigational Site, Wyoming
Vanda Investigational Site, Minneapolis
Vanda Investigational Site, Elgin
Vanda Investigational Site, St Louis
Vanda Investigational Site, Marrero
Vanda Investigational Site, Little Rock
Vanda Investigational Site, Tulsa
Vanda Investigational Site, Richardson
Vanda Investigational Site, Houston
Vanda Investigational Site, El Paso
Vanda Investigational Site, Tucson
Vanda Investigational Site, Los Angeles
Vanda Investigational Site, Chula Vista
Vanda Investigational Site, San Francisco
Vanda Investigational Site, Palo Alto
Vanda Investigational Site, Boston
Vanda Investigational Site, Boston
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY